Prophylactic Effect of Memantine in Chronic Tension-Type Headache - Tabular View

Tracking Information

First Received Date ^ICMJE

April 18, 2006

Last Updated Date

February 19, 2009

Start Date ^ICMJE

May 2006

Primary Completion Date

June 2007 (final data collection date for primary outcome measure)

Current Primary Outcome Measures ^ICMJE

Headache duration
Headache intensity

Original Primary Outcome Measures ^ICMJE

Same as current

Change History

Complete list of historical versions of study NCT00315666 on ClinicalTrials.gov Archive Site

Current Secondary Outcome Measures ^ICMJE

Headache frequency
The use of simple analgesics
Side effects

Original Secondary Outcome Measures ^ICMJE

Same as current

Descriptive Information

Brief Title ^ICMJE

Prophylactic Effect of Memantine in Chronic Tension-Type Headache

Official Title ^ICMJE

Prophylactic Effect of Memantine in Chronic Tension-Type Headache

Brief Summary

The purpose of this study is to test whether memantine has a prophylactic effect on chronic tension-type headaches.

Detailed Description

Study Phase

Phase III

Study Type ^ICMJE

Interventional

Study Design ^ICMJE

Treatment, Randomized, Double-Blind, Placebo Control, Crossover Assignment, Efficacy Study

Condition ^ICMJE

Tension-Type Headache

Intervention ^ICMJE

Drug: memantine

Study Arms / Comparison Groups

Publications *

* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.

Recruitment Information

Recruitment Status ^ICMJE

Completed

Enrollment ^ICMJE

Completion Date

June 2007

Primary Completion Date

June 2007 (final data collection date for primary outcome measure)

Eligibility Criteria ^ICMJE

Inclusion Criteria:

Chronic tension-type headache
Normal urine pH

Exclusion Criteria:

More than 1 migraine attack/month
Other major illnesses
Overuse of medicine/alcohol
Women not using AC
Pregnant/breast-feeding women
Allergy to memantine

Gender

Both

Ages

18 Years to 65 Years

Accepts Healthy Volunteers

Contacts ^ICMJE

Contact information is only displayed when the study is recruiting subjects

Location Countries ^ICMJE

Denmark

Administrative Information

NCT ID ^ICMJE

NCT00315666

Responsible Party

Study ID Numbers ^ICMJE

2006-000060-82, KA-20060021

Study Sponsor ^ICMJE

Danish Headache Center

Collaborators ^ICMJE

Investigators ^ICMJE

Principal Investigator:

Lars Bendtsen, MD, PhD

Danish Headaches Center, Dept. of Neurology, KAS Glostrup, DK-2600 Glostrup

Information Provided By

Danish Headache Center

Verification Date

February 2009

^ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP